A Novel Combination Oral Agent to Treat Acne Vulgaris,.... (12345)

Recruiting
13 years - 60 years
All
Fase 1/2
60 participants needed
2 Locations

Brief description of study

The purpose of this study is to evaluate a novel, combination product for the treatment of acne vulgaris in females

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: ACNE VULGARIS
  • Age: 13 years - 60 years
  • Gender: All

Inclusion Criteria:

  • Healthy females 13 years of age or older
  • Non-pregnant, non-lactating females
  • Signed written informed consent form
  • Must be able to understand and be willing to follow all study instructions
  • Have a clinical diagnosis of acne vulgaris

Exclusion Criteria:

  • Female subjects who are pregnant or nursing
  • Any concomitant dermatologic condition that may affect outcome measures
  • Concurrent use of any other medication to treat acne vulgaris
  • Have a history or clinical evidence of any other active acute or chronic medical disease or condition considered by the principal investigator as unsuitable for the study
  • Are currently using any other investigational agent or device
  • Have participated in any other clinical study within 90 days prior to enrollment
  • Employees or family members of sponsor or research site

Updated on 18 Feb 2011. Study ID: NCT01301586

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language